Compounds > clinafloxacin
Page last updated: 2024-08-24

clinafloxacin and Endocarditis, Bacterial

clinafloxacin has been researched along with Endocarditis, Bacterial in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eiseman, I; Holley, HP; Levine, DP; Tack, K; Willcox, P1
Donabedian, SA; Perri, MB; Thal, LA; Vazquez, J; Zervos, MJ1
Burney, S; Landman, D; Quale, JM; Zaman, MM1
Coyle, EA; Hershberger, E; Kaatz, GW; Rybak, MJ; Zervos, MJ1
Bailey, EM; Kaatz, GW; Lamp, KC; Rybak, MJ; Seo, SM1

Trials

1 trial(s) available for clinafloxacin and Endocarditis, Bacterial

ArticleYear
Clinafloxacin for the treatment of bacterial endocarditis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Mar-01, Volume: 38, Issue:5

    Topics: Adult; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Prosthesis; Humans; Male; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome

2004

Other Studies

4 other study(ies) available for clinafloxacin and Endocarditis, Bacterial

ArticleYear
Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:5

    Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gentamicins; Gram-Positive Bacterial Infections; Quinolones; Rabbits; Random Allocation

1993
Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxacin and penicillin.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Penicillins; Quinolones; Rabbits

1996
Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7

    Topics: Animal Testing Alternatives; Animals; Anti-Infective Agents; Blood Platelets; Cattle; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Enterococcus; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Naphthyridines; Rabbits; Staphylococcus aureus

2000
CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:6

    Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Fluoroquinolones; Kidney; Male; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rabbits; Spleen; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1992